347 related articles for article (PubMed ID: 25846476)
41. Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis.
Wang M; Yu H; Li Z; Gong D; Liu X
Am J Cardiovasc Drugs; 2022 Nov; 22(6):657-675. PubMed ID: 35570250
[TBL] [Abstract][Full Text] [Related]
42. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
[TBL] [Abstract][Full Text] [Related]
43. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
44. Aspirin for Primary Prevention of Cardiovascular Events.
Abdelaziz HK; Saad M; Pothineni NVK; Megaly M; Potluri R; Saleh M; Kon DLC; Roberts DH; Bhatt DL; Aronow HD; Abbott JD; Mehta JL
J Am Coll Cardiol; 2019 Jun; 73(23):2915-2929. PubMed ID: 31196447
[TBL] [Abstract][Full Text] [Related]
45. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan.
Ishikawa S; Inaba T; Mizuno M; Okada H; Kuwaki K; Kuzume T; Yokota H; Fukuda Y; Takeda K; Nagano H; Wato M; Kawai K
Acta Med Okayama; 2008 Feb; 62(1):29-36. PubMed ID: 18323869
[TBL] [Abstract][Full Text] [Related]
46. Prevention of Upper Gastrointestinal Ulcer and Complications in Low-Dose Aspirin Users.
Sugano K
Curr Pharm Des; 2015; 21(35):5082-8. PubMed ID: 26369684
[TBL] [Abstract][Full Text] [Related]
47. Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism.
Shiotani A; Fujita Y; Nishio K
Curr Pharm Des; 2015; 21(35):5066-72. PubMed ID: 26369686
[TBL] [Abstract][Full Text] [Related]
48. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study.
Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK
Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193
[TBL] [Abstract][Full Text] [Related]
49. Aspirin and gastrointestinal bleeding risk in older people.
Drug Ther Bull; 2021 Aug; 59(8):117. PubMed ID: 34210661
[No Abstract] [Full Text] [Related]
50. Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
Tan HJ; Mahadeva S; Menon J; Ng WK; Zainal Abidin I; Chan FK; Goh KL; ;
J Dig Dis; 2013 Jan; 14(1):1-10. PubMed ID: 23134105
[TBL] [Abstract][Full Text] [Related]
51. Gastroprotection in low-dose aspirin users for primary and secondary prevention of ACS: results of a cost-effectiveness analysis including compliance.
de Groot NL; van Haalen HG; Spiegel BM; Laine L; Lanas A; Focks JJ; Siersema PD; van Oijen MG
Cardiovasc Drugs Ther; 2013 Aug; 27(4):341-57. PubMed ID: 23417566
[TBL] [Abstract][Full Text] [Related]
52. Cardioprotective effects and gastrointestinal risks of aspirin: maintaining the delicate balance.
Kimmey MB
Am J Med; 2004 Sep; 117 Suppl 5A():72S-78S. PubMed ID: 15478856
[TBL] [Abstract][Full Text] [Related]
53. Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
Targownik LE; Metge CJ; Leung S
Aliment Pharmacol Ther; 2008 Jul; 28(1):88-96. PubMed ID: 18410563
[TBL] [Abstract][Full Text] [Related]
54. [Digestive and hemorrhage complications of low-dose aspirin].
Sibilia J; Ravaud P; Marck G
Presse Med; 2003 Nov; 32(37 Pt 2):S17-28. PubMed ID: 14763350
[TBL] [Abstract][Full Text] [Related]
55. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
Soubra L; Issa M
Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
[TBL] [Abstract][Full Text] [Related]
56. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A
Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042
[TBL] [Abstract][Full Text] [Related]
57. Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.
Lanas A; Gargallo CJ
J Gastroenterol; 2015 Jun; 50(6):626-37. PubMed ID: 25595209
[TBL] [Abstract][Full Text] [Related]
58. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
59. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
[TBL] [Abstract][Full Text] [Related]
60. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
